Skip to content

FAMILY Sleep Program

FAMILY Sleep Program

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06571305
Enrollment
18
Registered
2024-08-26
Start date
2024-08-01
Completion date
2027-10-01
Last updated
2026-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

The purpose of this study is to learn about sleep behaviors and test different ways to help patients with cancer and partners. Participants (patient-sleep-partner caregivers dyads as a unit) participate in the study together.

Interventions

BBTI is brief patient-focused intervention for patient-sleep-partner caregiver dyads, aimed at altering participants' sleep behaviors to improve sleep. BBTI utilizes behavioral education in sleep restriction and stimulus control. For sleep restriction, participants will be instructed to limit the time spent in bed, which serves to increase sleep efficiency. For stimulus control, participants will be instructed to go to bed only when feeling sleepy and reserve the bed for sleep and intimacy. BBTI will be delivered over four weeks, in weekly one-hour sessions, one session per week.

BEHAVIORALMy Sleep Our Sleep (MSOS)

MSOS is a sleep intervention developed by the investigator aimed at improving sleep health for patient-sleep-partner caregiver dyads using behavioral education in sleep behaviors, sleep cognition and sleep in relationship. MSOS will be delivered over four weeks, in weekly one-hour sessions, one session per week.

Sponsors

University of Miami
Lead SponsorOTHER
Community Foundation for Brevard
CollaboratorUNKNOWN

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* The eligibility criteria for patients are * newly diagnosed with stage I to IV of a solid tumor * diagnosis in the past seven years at the time of enrollment * having a consistent sleep partner. * The eligibility criterion for caregivers is * a sleep partner of the patient. * Additional eligibility criteria for both patients and caregivers are * Pittsburgh Sleep Quality Index (PSQI) ≥ 5, * willing to change sub-optimal sleep habits, * 18 years or older, * able to speak/listen English at the 8th grade level for intervention sessions, * able to read English or Spanish at the 8th grade for self-reported questionnaires, reside in Brevard County, Florida (FL), * only for participants of Aim 2, \> 4 weeks after surgery, if any, prior to enrollment, and no surgery planned in the next 5 weeks during the study period because surgery affects sleep.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants adapting to BBTIUp to 4 weeksThe proportion of participants (patient--sleep-partner caregiver dyads) who adapt to Brief Behavioral Treatment for Insomnia (BBTI).
Change in Sleep Disturbance Symptoms Measured by Pittsburgh Sleep Quality Index (PSQI)Baseline, Up to 4 weeksThe proportion of participants (patient-sleep-partner caregiver dyads) experiencing a change in sleep disturbance symptoms will be compared and reported for both intervention groups, BBTI and MSOS, as measured by scores on the Pittsburgh Sleep Quality Index (PSQI) health-related quality of life HRQOL) questionnaire. The PSQI is a self-reported, 19-item questionnaire which assesses sleep quality and disturbances at baseline and over a four week period. Questions generate seven "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. The sum of scores for these seven components yields one global score. The PSQI global score has a possible range of 0-21 points. A total score of 5 or above indicates overall poor sleep quality.

Countries

United States

Contacts

CONTACTYoungmee Kim, PhD
ykim@miami.edu305-284-5439
PRINCIPAL_INVESTIGATORYoungmee Kim, PhD

University of Miami

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 15, 2026